FDA Approves Moderna's Next-Generation COVID-19 Vaccine for Adults 65+
TL;DR Summary
The FDA has approved Moderna's new lower-dose COVID-19 vaccine, mNexspike, for use in adults 65+ and at-risk individuals aged 12-64, providing an additional tool for COVID-19 protection, especially for high-risk groups, based on a study showing it is safe and effective.
- FDA approves Moderna's new lower-dose COVID-19 vaccine ABC News
- FDA approves new Moderna COVID-19 vaccine Axios
- FDA approves a next-generation Covid vaccine from Moderna, with restrictions statnews.com
- The FDA Just Approved a New Covid Vaccine Mother Jones
- US FDA approves Moderna's next-generation COVID vaccine for adults 65 or older Reuters
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
2 min
vs 2 min read
Condensed
88%
354 → 41 words
Want the full story? Read the original article
Read on ABC News